NCT03931369View on ClinicalTrials.gov

Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)

PHASE2UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 6, 2019

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

Tolvaptan 15 MG

Single administration of one pill of 15 MG tolvaptan

Trial Locations (1)

75015

AP-HP Hôpital Européen Georges Pompidou, Paris

Sponsors
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Europe Ltd

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) | Biotech Hunter | Biotech Hunter